Press Releases
Public Relations: Andrew Noble
DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years
World’s largest biomedical research resource now features more than 28 PB of data to help accelerate scientific discovery and improve human health
DNAnexus Announces Appointment of Thomas Laur as CEO
Proven healthcare executive brings decades of experience leading successful software, data, and services companies. Richard Daly remains actively involved as a member of the Board of Directors
DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation
Complete collaborative environment with intuitive interface addresses common analysis challenges to help accelerate transition from scientific discovery to data-driven precision medicine
Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data
Comprehensive cloud platform provides industry-leading data quality, security, privacy, and compliance for ongoing service that screens for more than 300 inherited conditions with automated annual re-analysis
DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico
DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico
News
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies.
Blackstone Growth Leads $200 Million Investment in DNAnexus
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital